By May 5, 2025, the Trump administration will file its first brief in
and Drug Administration, staking out a position in the case on whether it will continue to defend the Food and Drug Administration’s regulation of mifepristone.
By May 5, 2025, the Trump administration will file its first brief in
and Drug Administration, staking out a position in the case on whether it will continue to defend the Food and Drug Administration’s regulation of mifepristone.